Home » Topics » Science » New compound

New compound
RSS

177Lu-DOTAGA.(SA.FAPi)2 use for thyroid cancer

June 18, 2021

Noncovalent approach using monobodies selectively recognizes and inhibits oncogenic RAS mutants

June 7, 2021

BTK-selective degrader NX-5948 reduces inflammation in a murine model of rheumatoid arthritis

June 7, 2021

EC-11770 shows broad-spectrum activity in nontuberculous mycobacterial infection models

June 1, 2021

Novel RIPK2 inhibitor for the treatment of IBD

May 27, 2021

New Angex Pharmaceutical anticancer compounds show preclinical potential

May 13, 2021

BIRKI, a novel ROCK inhibitor as potential new therapy for diabetic retinopathy

May 12, 2021

Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment

May 11, 2021

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

May 10, 2021

Discovery and preclinical characterization of novel bifunctional anti-PD-1 x IL-15 proteins

May 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...